← Leaderboards
Kevin D Bunker
Kalyra Pharmaceuticals, Inc.
$2,469,684
Attributed
$2,469,684
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2015–17$2M$1.5M$1M$500K$0
'15
'16
'17
Funding mix
By agency
NIH$2,469,684 · 1
By mechanism
R44$2,469,684 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Drug Kinetics”
- Leonard Freedman · Leidos Biomedical Research, Inc.$241,865,009
- Sharon A Nachman · Johns Hopkins University$194,646,762
- Carol Nesel · Westat$147,274,423
- Barbara Driver · Westat, Inc.$103,746,400
- Ronald T Mitsuyasu · University Of California Los Angeles$99,239,507
- Lynn Briscoe · Leidos Biomedical Research, Inc.$93,714,869
Research focus
Drug KineticsAcuteAcetaminophenAcute PainAddictionAdverse EffectsAcute Liver FailureAnalogAntidepressive AgentsAntiepileptic AgentsBaseCanis FamiliarisCardiacCessation Of LifeChronic PainAnalgesicsClinical TrialsComparative EfficacyCostCoxibsDisability PaymentDoseDrug CandidateEffective Therapy
Grant awards (3)
A new class of non-opioid analgesics for use in chronic pain management$94,924
R44 · FY2017 · DA · contact PI
A new class of non-opioid analgesics for use in chronic pain management$1,131,822
R44 · FY2016 · DA · contact PI
A new class of non-opioid analgesics for use in chronic pain management$1,242,938
R44 · FY2015 · DA · contact PI